Literature DB >> 2463378

Inhibition of human T-cell leukemia virus type I replication in primary human T cells that express antisense RNA.

T von Rüden1, E Gilboa.   

Abstract

The human T-cell leukemia virus type I is associated with adult T-cell leukemia-lymphoma in humans, a disease which is induced by a malignant transformation of T lymphocytes. Retrovirus vectors carrying human T-cell leukemia virus type I-derived sequences in reversed transcriptional orientation were used to express antisense RNA transcripts in primary human leukocytes. Human T-cell leukemia virus type I replication and virus-mediated immortalization were inhibited in cells harboring antisense constructs. This study suggests that retrovirus-mediated antisense RNA inhibition can be used to protect primary human T-lymphocytes from human T-cell leukemia virus type I-mediated cell transformation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2463378      PMCID: PMC247738     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells.

Authors:  M Wigler; S Silverstein; L S Lee; A Pellicer; Y c Cheng; R Axel
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

3.  Suppression of endo B cytokeratin by its antisense RNA inhibits the normal coexpression of endo A cytokeratin.

Authors:  K Trevor; E Linney; R G Oshima
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

4.  Inhibition of retroviral replication by anti-sense RNA.

Authors:  R Y To; S C Booth; P E Neiman
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

Review 5.  The role of antisense RNA in gene regulation.

Authors:  P J Green; O Pines; M Inouye
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

6.  Transcriptional (p40x) and post-transcriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes.

Authors:  J Inoue; M Yoshida; M Seiki
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

7.  Effect of internal viral sequences on the utility of retroviral vectors.

Authors:  D Armentano; S F Yu; P W Kantoff; T von Ruden; W F Anderson; E Gilboa
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

8.  Antisense RNA of proto-oncogene c-fos blocks renewed growth of quiescent 3T3 cells.

Authors:  K Nishikura; J M Murray
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

9.  Antisense RNA inactivation of myosin heavy chain gene expression in Dictyostelium discoideum.

Authors:  D A Knecht; W F Loomis
Journal:  Science       Date:  1987-05-29       Impact factor: 47.728

10.  Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins.

Authors:  M Hidaka; J Inoue; M Yoshida; M Seiki
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more
  11 in total

1.  Inhibition of human immunodeficiency virus replication in a human T cell line by antisense RNA expressed in the cell.

Authors:  J Gyotoku; M A el-Farrash; S Fujimoto; W T Germeraad; Y Watanabe; K Teshigawara; S Harada; Y Katsura
Journal:  Virus Genes       Date:  1991-07       Impact factor: 2.332

Review 2.  Gene therapy for infectious diseases.

Authors:  B A Bunnell; R A Morgan
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

3.  Lysolipid exchange with lipid vesicle membranes.

Authors:  D Needham; D V Zhelev
Journal:  Ann Biomed Eng       Date:  1995 May-Jun       Impact factor: 3.934

4.  Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication.

Authors:  B A Sullenger; T C Lee; C A Smith; G E Ungers; E Gilboa
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

Review 5.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

6.  Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors.

Authors:  G Podsakoff; K K Wong; S Chatterjee
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

7.  Inhibition of human immunodeficiency virus type 1 multiplication by antisense and sense RNA expression.

Authors:  S Joshi; A Van Brunschot; S Asad; I van der Elst; S E Read; A Bernstein
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

8.  Antisense therapy of hepatitis B virus infection.

Authors:  W B Offensperger; S Offensperger; H E Blum
Journal:  Mol Biotechnol       Date:  1998-04       Impact factor: 2.695

9.  Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: identification of an essential gene.

Authors:  A Ripalti; M C Boccuni; F Campanini; M P Landini
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides.

Authors:  W B Offensperger; S Offensperger; E Walter; K Teubner; G Igloi; H E Blum; W Gerok
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.